Tricyclic compounds as TXA.sub.2 antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514245, 514246, 514248, 514249, 514258, 514299, 514300, 514301, 514302, 514303, 544180, 544211, 544212, 544219, 544235, 544236, 544253, 544264, 544278, 544280, 544349, 544350, 546112, 546113, 546114, 546115, 546117, 546118, A61K 31435, A61K 31505, C07D47104, C07D47300

Patent

active

053025962

ABSTRACT:
Novel tricyclic compound represented by formula ##STR1## possess a TXA.sub.2 biosynthesis inhibiting activity and/or a TXA.sub.2 receptor antagonizing activity, and are expected to have preventive and therapeutic effects on ischemic diseases, cerebro-vascular diseases, etc.

REFERENCES:
patent: 3354155 (1967-11-01), Trette
patent: 3420851 (1969-01-01), Bloom
patent: 4282365 (1981-08-01), Rokach
patent: 4396550 (1983-08-01), Takizawa
patent: 4465835 (1984-08-01), Takizawa
patent: 4585788 (1986-04-01), Helsley
patent: 4596804 (1986-06-01), Takizawa
patent: 4749703 (1988-06-01), Uso
patent: 4882351 (1989-11-01), Oshima
patent: 4994463 (1991-02-01), Oshima
patent: 4999363 (1991-03-01), Oshima
patent: 5010087 (1991-04-01), Oshima
patent: 5010104 (1991-04-01), Oshima
patent: 5118701 (1992-06-01), Oshima
patent: 5143922 (1992-09-01), Oshima
patent: 5242931 (1993-09-01), Oshima et al.
Pinder Drugs, 13, 161-167 (1977).
Tsukada et al., J. Med. Chem., 21 (7) 633-639 (1978).
Uno et al., J. Med. Chem. 19 (7) 941-976 (1976).
Bemesovo, Arz. Forsch., 14, 100-105 (1964).
Melusova, Arz. Forsch., 13, 1039-1045 (1963).
Alluz, J. Med. Chem., 20 (11) 1499-1501 (1977).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tricyclic compounds as TXA.sub.2 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic compounds as TXA.sub.2 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compounds as TXA.sub.2 antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2098861

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.